Patent 9200270 was granted and assigned to AbbVie Inc. on December, 2015 by the United States Patent and Trademark Office.
This invention is directed to the transformation of yeast, and mutants thereof, by electroporation, which result in stably transformed yeast host cells that express recombinant products. This invention also is directed to transformed yeast cells and libraries.